Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Management is working hard on moving the company forward and also to maximize investors' interests. As any growth company, it all takes time. Patience is the key. Good luck to all who are investing here. I'm one of you.
Well, it's going to happen for whatever the reason. So, let's move on.
It is a 10% increase in your stock holdings. So, 10% x 1000 = 100 more shares. Total - 1100 shares.
Because I have a certificate. It is the paperwork and new replacement cert that the $15 covers. Street form shares don't require any paperwork. That is done electronically.
The press release states there will be a forward stock split effective on December 31, 2009, for holders of the stock on that date. You will receive 11 shares for every ten shares you hold. There will be a company name change and you will receive new CUSIP numbers. Please mail your certificated stocks to:
Olde Monmouth Stock Transfer Co., Inc.
200 Memorial Parkway
Atlantic Highlands, NJ 07716
Please include your check in the amount of $15.00 for the new cert.
The longs have been commenting for 13 days. At some point people are either in it or not. Otherwise, just move on. No point in repeating the same thing over and over. So, good luck and farewell.
http://shortsqueeze.com/?symbol=emge
This link corroborates that.
Wow, you are correct. That is way up from the 3600 short I saw last I looked. That will be very interesting indeed.
This is not the only stock that was suspended due to sudden rise in trading shares. It is normally a red flag and the SEC goes in and checks the float and shares traded. If it is on the up-and-up, no problems. One more day and hopefully all this trash talk will end. Nothing wrong with management. Please don't post libelous unfacts about them.
Thanks. I had not seen that one. I myself use Vita-Stim.
We shall soon see.
I did want to say here that I spoke with the Miami office of the SEC and I was assured that they were only looking into the number of shares issued by the company and the number of shares traded. Remember that a lot of shares turned over during that increase in trading activity. If you weren't aware of this, these kinds of sudden jumps in trades catches their "eye" and they just as a standard operating procedure check that out. They told me they were only looking at what the Order stated they were looking at and nothing more. It is not within their pervue to check anything else. I'm sure they have enough to do with the folks on the Street who do plenty of damage to innocent folks. It was interesting for me to see how wild folks got in different chats about this. Talk about great imaginations! Anyway, if the stock should drop below where I think it is a bargain, I'll be loading up. It is just starting a nice growth spurt and sales are increasing nicely.
If it helps any, I am holding a large position as well and it is underwater even at the suspension price. However, everyone has to make a decision based on their own situation...financial and otherwise. I happen to be in it for the long term because I consider this a growth company. If you need the funds or feel it would be better to take what you can get and either put it away or find something else, then that is the way for you to go. No one can tell another person what they should or should not do. As in anything else in life, we have to take responsibility for our decisions. I have been following the company for some time, so I know what has been and is being put into it. This is not a scam, as some would have you believe. But again, you must look at your own situation. I hope this helps.
We'll just have to see what happens. No predictions here. However, it is a company in its infancy and is finally starting to do pretty well considering what it takes to get a company going. So, they are pretty much on target. It takes approximately 2-3 years to get up and running. I know Dr. Cappello has been working very hard and putting in many hours.
As I posted here a few days ago, TRLG was one on the Pinks that I liked a lot. I think it was something like .85 and is over $28/share today. I have followed it for a long time now. They started it in one of the executive's living room because they had no capital for office space yet, but they stayed with their plan and tweaked it as they went along. Solid company.
Thank you for the positive post. I too use Vita-Stim and have found it to be very good. Dr. Cappello is working hard to get this company through this stage of development and getting name recognition as well. It takes time. He is totally dedicated to this venture and is a smart man. He is also an MBA, which serves him well in the business world. There will always be those malcontents who will paint every stock at this level with a broad brush and post things for their own benefit. Best to just do your own DD and go with your own findings. I simply choose to ignore folks who post that stuff just because it is so wide-spread and really viscious. I'll just wait and see what happens with all this.
Sorry to hear that. Anyway, I did find what the short interest was when the stock was suspended:
Monday October 5, 2009 20 Min Delayed
Short Quote™
Enter Symbol:
Emergent Health Corp. $
EMGE
Short Interest (Shares Short) 3,600
Days To Cover (Short Interest Ratio) 4.5
Short Percent of Float %
Short Interest - Prior 9,100
Short % Increase / Decrease -60.44 %
Short Squeeze Ranking™
You are dragging everything but the kitchen sink in here. The SEC said in their order that they are looking at "Issued shares and shares traded." That's it. Why drag all this other junk in here? Until I see that the SEC is doing more than the above and posts the order, I think we should just end all this blather here.
What other scams? TIA
Janice, no way would Dr. Cappello spend $700K like that. He is way too conservative. As far as I know, the SEC stated that they are looking at numbers of shares issued vs. numbers traded. Nothing more that I am aware of. I called and spoke with them. Therefore, all else is just speculation. I'll just wait to hear the results on 10/14. It will be what it will be and life will go on.
Well, I do know Dr. Cappello did not pay that kind of money to promoters. Certainly the company profits couldn't have been sufficient and all money goes right back into running the company. He has taken no compensation for his work and I know he would not have spent hundreds of thousands of dollars of his own money for that. However, I digress. Let's wait and see what we find out.
None of it is true. No way would those amounts be paid.
Well, if PSP lied the SEC will find them. That is false information to the public.
Been trading some. Been busy with trying to get myself and my home together, along with being a monitor in a Yahoo group. I left my job and moved to Central Texas, so it has been an adjustment, and still a lot to do. My garage serves as a storage place at present, so I need to tackle that soon and also paint in there. When one moves from a condo to a house, it is almost like starting all over again. I procrastinate a lot. I hope you are all doing well.
Hi all!! Long time no visit. I happened by today and read your discourse going on here. Thought you might want something else for fodder :)
http://www.newswithviews.com/Devvy/kidd29.htm
ACTC news today: Cells Show Ability to Repair Vascular Damage in Animals
-New, scalable population of hemangioblast cells halves the death rate
following heart attack and repairs ischemic limbs and damaged
vasculature-
WORCESTER, Mass.--(BUSINESS WIRE)--May 07, 2007--
Advanced Cell Technology, Inc. (OTCBB: ACTC) reported for the first time that
hemangioblast precursor cells derived from human embryonic stem (hES) cells can
be used to achieve vascular repair. The research, which appears today online
(ahead of print) in the journal Nature Methods, by Advanced Cell Technology
(ACT) and its collaborators, describes an efficient method for generating large
numbers of bipotential progenitors--known as hemangioblasts--from hES cells
that are capable of differentiating into blood vessels, as well as into all
blood and immune cell lineages.
"The ability to repair vascular damage using these cells could have a
profound impact on a large number of diseases that are major human
afflictions," said Robert Lanza, M.D., Vice President of Research & Scientific
Development at ACT, and senior author of the study. "Our results suggest the
possibility of using nature's early cellular developmental components to
restore vascularization and function in patients with vascular disease. An
injection of these cells may be able to prevent a patient from having a leg
amputated or from dying after a heart attack."
"We have developed for the first time a simple and highly scalable source of
human hemangioblasts," stated Shi-Jiang Lu, Ph.D., Director of Differentiation
at ACT and first author of the paper. "These proprietary cells represent a new
and distinctly different population of cells that can be differentiated into
vascular structures and multiple hematopoietic cell types. The elimination of
serum and other animal components from the system, as well as the ability to
generate an unlimited supply of these cells, will be important for future
preclinical and human studies."
When the cells were injected into animals that had damage to their retina due
to diabetes or ischemia-reperfusion injury (lack of adequate blood flow) of the
retina, the cells homed to the site of injury and showed robust reparative
function of the entire damaged vasculature within 24-48 hours. The cells showed
a similar regenerative capacity in animal models of both myocardial infarction
(50% reduction in mortality rate) and hind limb ischemia, with restoration of
blood flow to near normal levels.
"These cells were able to generate functional blood vessels in the presence
of severe tissue injury, as well as in chronic disease states," says Maria
Grant, M.D., Professor of Pharmacology at the University of Florida, and an
author on the paper. "These cells have a robust vascular reparative ability
under what is typically considered very adverse growth conditions making them
potentially ideal for treatment of diabetic vascular complications where
profound tissue compromise exists and healing is typically severely
compromised."
"While the cells in this study were tested in animal models, we believe this
breakthrough has the potential to benefit many Americans suffering from
vascular disease," stated William M. Caldwell, IV, Chairman and CEO of Advanced
Cell Technology. "ACT is committed to moving this technology from the
laboratory into the clinic. We plan on filing an Investigational New Drug
Application with the Food and Drug Administration for the first clinical
application of these cells by the end of next year."
The researchers of the paper from Advanced Cell Technology collaborated with
scientists from the University of Florida, Gainesville, Florida, and the
Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York. The paper's
other authors are Qiang Feng of ACT, Sergio Caballero of the University of
Florida, and Yu Chen and Malcolm A.S. Moore, DPhil, of MSKCC.
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying embryonic
stem cell technology in the emerging field of regenerative medicine. The
company operates facilities in Alameda, California and Worcester,
Massachusetts.
For more information, please visit: www.advancedcell.com.
Forward-Looking Statements
Statements in this news release regarding future financial and operating
results, future growth in research and development programs, potential
applications of our technology, opportunities for the company and any other
statements about the future expectations, beliefs, goals, plans, or prospects
expressed by management constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Any statements
that are not statements of historical fact (including statements containing the
words "will," "believes," "plans," "anticipates," "expects," "estimates," and
similar expressions) should also be considered to be forward-looking
statements. There are a number of important factors that could cause actual
results or events to differ materially from those indicated by such
forward-looking statements, including: limited operating history, need for
future capital, risks inherent in the development and commercialization of
potential products, protection of our intellectual property, and economic
conditions generally. Additional information on potential factors that could
affect our results and other risks and uncertainties are detailed from time to
time in the company's periodic reports, including the annual report on Form
10-KSB for the fiscal year ending December 31, 2006.
Forward-looking statements are based on the beliefs, opinions, and
expectations of the company's management at the time they are made, and the
company does not assume any obligation to update its forward-looking statements
if those beliefs, opinions, expectations, or other circumstances should change.
CONTACT: Media
FD
Robert Stanislaro, 212-850-5657
or
Investors
The Investor Relations Group
Joseph Kessler or James Carbonara
212-825-3210
SOURCE: Advanced Cell Technology, Inc.
Copyright Business Wire 2007
(END) Dow Jones Newswires
05-07-07 1308ET
13:08 050707
RCAU: I've traded this one several times. I get in under $4 and exit somewhere over $4.25. Actually, each time it has gone higher after I exit, so may just do trailing stops in it this time. Got back in after the drop last week.
Watch TASR tomorrow. With the French election having been won by Sarkozy, this could really move. He stated that if he won the election, he would see that every police car in France was equipped with a taser.
I did trade DNDN on Thursday and got a nice profit, but holding just a little of it for next week. I would not be short this stock. The shorts will be very nervous imo, so it will be pretty volatile. Look at the calls on it. That should tell us something. It's a gamble anyway, but odds are pretty good for FDA to approve.
Re DNDN: This is a view from someone on investorvillage. I found it more than interesting. I would love to hear what the pros think of this. having an interest in pharm the trading activity squares with what this chap says. I doubled my position Thursday morning and so far am happy with things.
Dee
The light bulb went off in someone's head on Wall Street on
Thursday... Someone on Wall Street took a careful look at DNDN on Thursday morning, and like the ship captain in the Poseidon Adventure they looked out and saw the coming tsunami and said "OH MY GOD, turn on those buy programs now, TURN THEM ON!"
Some of the shorts will go bankrupt and will be out of business
before this is over.
Stocks are not supposed to do what DNDN did on Thursday, ever. The jump last Friday and the 92 million share day were predictable if Provenge received a strong endorsement from the advisory committee, which it did. Stocks that jump on news are supposed to see their volume decline about in half each of the next several trading days as the story runs out of legs and normal trading resumes. Volume in DNDN fell to 13 million shares on Wednesday. This is exactly what DNDN was doing until about one hour into trading on Thursday, then someone on Wall Street hit the panic buy button.
DNDN went on to trade 60 million shares on Thursday and climb almost 20% on no new news, no analyst upgrades, no events at all that should have caused the stock to trade more than 10 million shares on a get out of town day before the three day weekend.
Now, why has it taken a week for what is about to happen to soak in to someone' mind with access to the buy button on Wall Street? First, and remember this, this has never happened before in this way in the history of Wall Street. You have never had such a leveraged bet to the downside that was so incredibly stupid and wrong going into an event that has almost unlimited upside without the shorts, a chance to own some of the only 82 million shares in the world of the company with the biggest breakthrough in cancer since surgery and radiation.
Second, and equally important, you have never had such corrupt and lopsided and wrong analysis passed off as research since probably the late 1920's. Hence, there is not a single research report someone on Wall Street can pick up and read and say WOW, Provenge is a $2 billion plus drug and DNDN is worth 5 to 20 times that $2 billion figure, discounted back for risk and time. That discounted value is triple digits in and of itself. The analysts were still out screaming in the press on Friday and Monday that the FDA would not approve what their advisory panel just voted overwhelmingly to approve, now that's corrupt.
On Thursday, when the buy button was hit on the buy program, it
quickly took out an unprepared line of defense at $15.40. The shorts attempted to regroup at $15.88, $16, $16,72, and $17. All of these lines of defense were quickly over-run and the buying program marched straight to $18. This is where the shorts were able to regroup and throw everything they had to stop the wave. However, the only thing they have left to fight with is MORE NAKED SHORTING. So, at the end of the day, net-net, there may actually have been an increase in the short position because of the three hour and 40 million share fight Thursday afternoon to defend or breakthrough $18.
Now, if you have not fully comprehended what I have just written in setting the stage, then stop here and go back and re-read it before you move on to read about the coming Tsunami and the light bulb that went off in some Wall Street Captains head.
First, this person realized that the ASS (Ashcoff, Shenouda, &
Sendek) team of analysts are lying. The FDA will 100% not keep
Provenge off the market to run the 9902B study, that's right I said 100%. The only risk to approval by May is the CMC section (which is so far so good), or some excuse like working on the safety plan so that the FDA can approve Provenge subject to a 90 day delay which would really be about finishing enrollment in 9902B by mid summer. I give the odds of approval in May 98% and the odds of approval in 2007 99.98%. This Wall Street Captain knows approval of a billion dollar cancer drug in a now small cap company is only weeks away, maybe only days away.
Second, the stock is so heavily shorted that almost every brokerage firm on Wall Street has a negative imbalance (naked short) position. This means in a couple of days, if the brokerage firm does not come into balance by locating more shares to borrow or by buying back DNDN to close out the imbalance, then the brokerage firm can not sell more
stock short without first having the shares borrowed in advance or having a stock certificate in advance. No more sell today and I will come up with my certificate or borrowed shares on Tuesday. It will all be C.O.D. for the short side. Now, it is a mistake to think the naked short position has to be covered next week, it does not. It is just that no new shorting in size can occur until DNDN comes off the Reg SHO list. The shorts have lost CNBC, their analyst henchmen have lost all credibility and will not be quoted with nonsense like no approval in any stories going forward, and it will keep seeping in on Wall Street that approval is in the bag and Provenge is a multi-billion dollar drug. My guess is over 30 million shares were still sold short at the close of business on Thursday.
Now, again, go back and re-read before moving forward if you didn't fully comprehend what was just written. The Provenge story is a triple digit story. Unwinding the short position in DNDN is a second triple digit story on its own.
There is a third independent triple digit story which is exploding now and will keep exploding over the next few weeks. The call options for April and May are going to be exercised en masse. Today, there are over 25 million April and May options to buy DNDN stock at $10 or less. Most of these deep in the money calls will be exercised and not sold and the market makers and call sellers must deliver over 20 million shares to the owners of these calls in the next few weeks. And because of Reg SHO they can not deliver phantom shares. This is no OSTK people, this is the biggest story on Wall Street and all eyes
are on it. The SEC knows it and every compliance department knows it on the Street.
The fourth independent triple digit wave that may hit DNDN is all of the other call options that may soon be deep in the money for April and May followed by all of the August call options. There are over 8 million more April and May calls written at $12 1/2 and $15 that are now deep in the money and will be much deeper when this stock rolls into the mid 20's next week. There are over 5 million August calls that are deep in the money now.
DNDN was the second most active stock in the market on no news on Thursday. DNDN was the 6th largest gainer on no new news on Thursday. Some Wall Street Captain chose to hit the panic buy button on Thursday. Everyone on Wall Street will want to figure out just what the guy who hit the panic buy button knows come early Monday morning.
What he knows is economics 101, supply and demand. There is
tremendous demand over the next several days and weeks for shares of DNDN and there are not nearly enough shares to satisfy demand. DNDN is right now in the early stages of hits parabolic run, not the late stages. There has never been three separate triple digit per share circumstance in one stock in the history of Wall Street before. Well, there is now baby, there is now. Forget the fundamentals, this is now all about froth and survival.
If you want to see $100 by May, then do not sell a single share next week. If you have margin, then move some of the DNDN shares that are no longer needed to support the margin account to the cash account (remember it is not an all or nothing proposition). If you own calls at $10 or less for April, then exercise them this week (you don't want to miss the big run and you don't want to pay ordinary gains anyway). If you can, buy more shares or start buying some of the November out of the money calls. The reason so many calls exist is because they are way to cheap and enticing. They will have to price the calls to a point where you think it is 50/50 to buy the calls or buy the stock, or the swelling call volume will not cease.
Everyone have a great Easter weekend and remember the heart of the Christian message is forgiveness. I believe the shorts will see enough punishment for there crimes and it will be so brutal no one with a memory will dare do what they did until the memory of this generation dies out. I am going to spend the weekend conditioning my heart to find compassion for the shorts. Lord knows they need it.
P.S. I do not have access to all of the different hedge fund
agreements, but it could be that some of the hedge fund clients
actually have liability if the hedge fund goes belly up. If you have a hedge fund find out if they have DNDN shares on the short side Monday morning and if they do, demand your money back immediately, while you still can.
Just checked Barcharts on NIHK, so thought I'd post the link if anyone is interested.
http://quotes.barchart.com/texpert.asp?sym=nihk
Anyone play DNDN this week? Traded it twice and holding over a few for next week. CEGE is another pharma that could be interesting. Nice volume in both. Cashed in on that RCAU Pinkie for a nice profit. Stocklemon put out a negative on them, so just a matter of time. Holding NIHK from .10 Has been looking interesting too lately.
NIHK...doing well. Posted that one here on Friday.
NIHK: Just a heads up on this one. Been holding it for a while now and finally got above water today. Another one I have is RCAU fyi.
PAE - One I have been slowly accumulating:
http://quotes.barchart.com/texpert.asp?sym=pae
Just call me swifty...:)
in BCON: Beacon Power Corporation (NASDAQ: BCON), a company that designs and develops
advanced products and services to support more stable, reliable and efficient
electricity grid operation, today announced that the New York State Energy
Research and Development Authority (NYSERDA) and the U.S. Department of Energy
(DOE) have confirmed the successful outcome of field trial testing of Beacon's
scale-power flywheel frequency regulation system in New York. In addition, the
New York ISO, which operates the power grid, determined that Beacon's
technology is viable for connection to the grid.
re GROW: AP
U.S. Global to Pay Dividend, Split Stock
Monday March 19, 2:21 pm ET
U.S. Global to Pay 25-Cent Dividend After 2-For1 Split of Traded and Privately Held Shares
SAN ANTONIO (AP) -- U.S. Global Investors Inc., an investment advisory firm, said Monday it plans to pay a special dividend after it completes a 2-for-1 stock split.
Shareholders of record as of March 19 will qualify on March 29 for one additional share of tradable Class A stock for each share of Class A stock and one non-tradable Class C share for each privately held Class C share.
ADVERTISEMENT
The stock split will double the number of shares outstanding and halve the price per share, but not affect the company's ownership ratios or market capitalization.
Amendments to the company's bylaws also permit the conversion of Class C to Class A stock. The company will handle conversion requests.
Also on March 29, shareholders of record on March 19 will receive a special dividend of 25 cents per share.
U.S. Global shares rose $4.45, or 11.8 percent, to $42.08 in afternoon trading on the Nasdaq Stock Market. The stock has ranged from $12.02 to $72.71 in the past year.
TECHNICAL CHART PATTERNS CHARACTERISTICS
Obtained from the book by Thomas N. Bulkowski, Encyclopedia of Chart Patterns
Note! Most technical Analysis chart patterns typically occur slowly over a 3 months to 4 months time span. Therefore, you should only
seriously use a weekly chart profile setting and at least
one-years worth of weekly time plots. .
TOP 10 BULLISH TECHNICAL CHART FORMATIONS WITH HIGHEST MOST LIKELY RISE! AVG.
FAILURES % AVG. RISE % LIKELY RISE %
1. Rounding Tops 6% 41% 30%
2. Broadening Formations, Right Angled
& Descending 19% 27% 25%
3. Scallops, Ascending 25% 33% 25%
4. Head-and-Shoulders Bottoms,
Complex 6% 37% 25%
5. Horn Bottoms 11% 37% 25%
6. Head-and-Shoulders Bottoms 5% 38% 25%
7. Double Bottoms 3% 40% 25%
8. Wedges, Falling 2% 43% 25%
9. Rectangle Top, Up Breakout 2% 52% 25%
10. Flags, High and Tight 17% 63% 25%
TOP 10 BEARISH TECHNICAL CHART FORMATIONS WITH HIGHEST MOST LIKELY DECLINE! AVG.
FAILURES % AVG. DECLINE % LIKELY DECLINE%
1. Pennant, trend down 34% 17% 25%
2. Scallops, Descending 3% 24% 20%
3. Head-and-Shoulders,
Tops, Complex 8% 27% 20%
4. Diamond Tops 25% 21% 20%
5. Broadening Wedges, Descending,
Down Breakout 41% 24% 20%
6. Rectangle Tops, Down Breakout 0% 20% 20%
7. Broadening Bottoms,
Down Breakout 6% 27% 17.5%
8. Bump-and-Run Reversal Tops 19% 24% 17.5%
9. Broadening Tops, Down breakout 4% 23% 15%
10.Triangles, Descending 4% 19% 15%
I believe what has happened is years ago when mostly Europeans came over to this country, through Ellis Island, they came as very hard-working people who had little, but worked hard even for that. They never complained about how little they had, but rather made the best of things. Then WWII came and many people had to escape with their very lives. They were eager to come to this country and build new lives, whatever that took. They got no handouts, had to learn English, and whatever they did, they did it as best they could and took pride in their work. My grandfather worked in a coal mine, grandmother took in sewing, etc., etc. to make ends meet and had small children with more on the way. No welfare was given nor was it wanted. It was felt that one had to earn ones way and never ever take something for nothing. Children had to be obedient and do well in school. Any complaints from teachers and they got it again when they got home, with grandmother waiting at the door with paddle in hand.
Now people want a lot for doing little to nothing. They feel they are "owed" everything for things they never even suffered themselves, and constantly complain that what they do get is never enough. We should support them and their children, and all the "toys" available. My grandparents never ever even had a car. Took buses or walked. Clothes were mostly sewn. Coats and other necessaties were not bad from Salvation Army and cost little. They were cleaned, fixed, starched, and looked good as new. We were very poor but we didn't know it. We ate modestly, but it was good. As you worked hard and made your way and slowly got new things, it was exciting and so much appreciated. Even now, I appreciate everything I have and never take anything for granted and am thankful every day for all of it. Things don't bring happiness. It is the way you live your life and what you do to help those who need help. That gives satisfaction no dollars can buy. My family has known what it is like to be poor and what it is like to have a few things, but we can live either way and never complain about it. Trouble is everything is expected, and the ACLU has been the major culprit in our society.
That is my two cents...
SMTX had good earnings AH. One I posted here several times last year. Only kept a few shares, but better than none.